Case Reports
doi: 10.1002/(sici)1097-0304(199811)45:3<318::aid-ccd23>3.0.co;2-2.
Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia
Affiliations
- PMID: 9829897
- DOI: 10.1002/(sici)1097-0304(199811)45:3<318::aid-ccd23>3.0.co;2-2
Item in Clipboard
Case Reports
Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia
Cathet Cardiovasc Diagn.
1998 Nov.
Abstract
Heparin is considered necessary during percutaneous coronary interventions; however, heparin is contraindicated in patients with heparin-induced thrombocytopenia and/or heparin antibodies. We describe the successful use of the heparinoid Orgaran (danaparoid sodium) in addition to abciximab (ReoPro) in a patient with heparin antibodies who required rotational atherectomy.
Similar articles
-
Combined use of Orgaran and Reopro during coronary angioplasty in patients unable to receive heparin.Catheter Cardiovasc Interv. 1999 Mar;46(3):352-5. doi: 10.1002/(SICI)1522-726X(199903)46:3<352::AID-CCD21>3.0.CO;2-7. Catheter Cardiovasc Interv. 1999. PMID: 10348139
-
Options to heparin anticoagulation for cardiac interventions.Catheter Cardiovasc Interv. 1999 Mar;46(3):356. doi: 10.1002/(SICI)1522-726X(199903)46:3<356::AID-CCD22>3.0.CO;2-0. Catheter Cardiovasc Interv. 1999. PMID: 10348140 No abstract available.
-
Heparinoid anticoagulation and topical fibrin sealant in heparin-induced thrombocytopenia.Ann Thorac Surg. 1997 Dec;64(6):1815-7. doi: 10.1016/s0003-4975(97)01065-5. Ann Thorac Surg. 1997. PMID: 9436582 Review.
-
Treatment of heparin-induced thrombocytopenia.J Thorac Cardiovasc Surg. 1997 Sep;114(3):517-8. doi: 10.1016/S0022-5223(97)70219-8. J Thorac Cardiovasc Surg. 1997. PMID: 9305220 No abstract available.
-
Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium.Eur J Pediatr. 1999 Dec;158 Suppl 3:S130-3. doi: 10.1007/pl00014338. Eur J Pediatr. 1999. PMID: 10650852 Review.
Cited by
-
Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Curr Cardiol Rep. 2001 Sep;3(5):362-70. doi: 10.1007/s11886-001-0052-7. Curr Cardiol Rep. 2001. PMID: 11504572 Review.
-
Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses.Blood Adv. 2020 Oct 27;4(20):5184-5193. doi: 10.1182/bloodadvances.2020002963. Blood Adv. 2020. PMID: 33095876 Free PMC article.
-
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.Blood Adv. 2018 Nov 27;2(22):3360-3392. doi: 10.1182/bloodadvances.2018024489. Blood Adv. 2018. PMID: 30482768 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
